X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (88) 88
humans (82) 82
oncology (69) 69
male (50) 50
female (47) 47
middle aged (46) 46
quality of life (45) 45
adult (41) 41
radiotherapy (33) 33
cancer (30) 30
aged (28) 28
clinical neurology (25) 25
glioma (25) 25
brain neoplasms - therapy (22) 22
brain neoplasms - drug therapy (20) 20
chemotherapy (19) 19
quality-of-life (19) 19
treatment outcome (19) 19
gliomas (18) 18
tumors (18) 18
glioblastoma (17) 17
brain neoplasms - complications (16) 16
brain neoplasms - pathology (16) 16
brain neoplasms - psychology (16) 16
brain neoplasms - radiotherapy (16) 16
temozolomide (16) 16
health-related quality of life (15) 15
brain tumors (14) 14
brain-tumors (14) 14
dacarbazine - analogs & derivatives (14) 14
glioma - complications (14) 14
medicine & public health (14) 14
surveys and questionnaires (14) 14
brain cancer (13) 13
brain neoplasms - mortality (13) 13
care and treatment (13) 13
clinical trials (13) 13
clinical-trials (13) 13
glioma - therapy (13) 13
hematology, oncology and palliative medicine (13) 13
palliative care (13) 13
prognosis (13) 13
radiation-therapy (13) 13
glioma - psychology (12) 12
survival (12) 12
survival analysis (12) 12
adolescent (11) 11
european-organization (11) 11
aged, 80 and over (10) 10
decision making (10) 10
disease-free survival (10) 10
epilepsy (10) 10
health status (10) 10
young adult (10) 10
antineoplastic agents, alkylating - therapeutic use (9) 9
brain (9) 9
brain tumor (9) 9
dacarbazine - therapeutic use (9) 9
disease progression (9) 9
follow-up studies (9) 9
high-grade glioma (9) 9
malignant glioma (9) 9
patient outcomes (9) 9
analysis (8) 8
brain neoplasms - genetics (8) 8
cognition (8) 8
cognitive function (8) 8
glioma - pathology (8) 8
humanities (8) 8
patients (8) 8
prognostic-factors (8) 8
proportional hazards models (8) 8
radiation (8) 8
research (8) 8
studies (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
cancer-patients (7) 7
cognition disorders - etiology (7) 7
combined modality therapy (7) 7
end of life (7) 7
glioblastoma - drug therapy (7) 7
health aspects (7) 7
kaplan-meier estimate (7) 7
lomustine - administration & dosage (7) 7
medical research (7) 7
neuropsychological tests (7) 7
oligodendroglioma - drug therapy (7) 7
oligodendroglioma - genetics (7) 7
phase-iii trial (7) 7
surgery (7) 7
time factors (7) 7
validation (7) 7
chemotherapy, adjuvant (6) 6
decision-making (6) 6
drug therapy (6) 6
fatigue (6) 6
glioblastoma multiforme (6) 6
glioma - drug therapy (6) 6
magnetic resonance imaging (6) 6
multiforme (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Opinion in Oncology, ISSN 1040-8746, 09/2019
PURPOSE OF REVIEWIncreased life expectancy in brain tumour patients had led to the need for strategies that preserve and improve cognitive functioning, as many... 
Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 3, pp. 344 - 350
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1100 - 1108
Journal Article
Lancet Oncology, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 943 - 953
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 35, pp. 5881 - 5886
Purpose O6-methylguanine-methyltransferase (MGMT) promoter methylation has been shown to predict survival of patients with glioblastomas if temozolomide is... 
SURVIVAL | GLIOMAS | TRIAL | GLIOBLASTOMA | HYPERMETHYLATION | ONCOLOGY | LOMUSTINE PLUS TEMOZOLOMIDE | GENE-EXPRESSION | RADIOTHERAPY | O-6-METHYLGUANINE-DNA METHYLTRANSFERASE | CANCER | Procarbazine - administration & dosage | Astrocytoma - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Oligodendroglioma - genetics | Humans | Middle Aged | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Gene Expression Regulation, Neoplastic | Oligodendroglioma - radiotherapy | Polymerase Chain Reaction - methods | Astrocytoma - pathology | DNA Methylation | Chromosomes, Human, Pair 1 | Time Factors | Tumor Suppressor Proteins - genetics | Astrocytoma - drug therapy | Vincristine - administration & dosage | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Astrocytoma - mortality | Oligodendroglioma - drug therapy | Astrocytoma - genetics | Chromosome Deletion | Promoter Regions, Genetic | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Europe - epidemiology | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Chromosomes, Human, Pair 19 | DNA Modification Methylases - genetics | Oligodendroglioma - pathology | CpG Islands | Lomustine - administration & dosage | Index Medicus | Original Reports | Neur8 | Neur1
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1521 - 1532
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2011, Volume 29, Issue 33, pp. 4430 - 4435
Purpose To investigate the generic and condition-specific health-related quality of life (HRQL) of patients with low-grade glioma (LGG). Patients and Methods A... 
BRAIN-TUMOR PATIENTS | IMPACT | ONCOLOGY | FATIGUE | VALIDATION | RADIOTHERAPY | RADIATION-THERAPY | Glioma - psychology | Brain Neoplasms - psychology | Humans | Middle Aged | Quality of Life | Adult | Female | Male | Cognition | Index Medicus
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2005, Volume 352, Issue 10, pp. 987 - 996
Journal Article